Senior Manager, SEC Reporting & Technical Accounting at Acadia Pharmaceuticals

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Licensed CPA required
Bachelor’s or master’s degree in accounting
Minimum 5 years of progressive accounting experience, including 2-3 years in a public company
Strong US GAAP and SEC compliance experience
Big Four experience auditing biotech companies strongly preferred
SEC reporting and technical accounting experience preferred
Experience in SOX 404(b) environment preferred
Workiva experience preferred
Strong analytical skills
Excellent written and verbal communication skills
Strong work ethic
Self-starter with ability to prioritize workload
Performs with strong sense of urgency and works effectively under deadlines
Attention to detail and ability to multi-task
Extensive biotechnology and/or pharmaceutical experience preferred

Responsibilities

Assist in the preparation of quarterly and annual SEC filings on Forms 10-K and 10-Q
Compile financial statements and footnote disclosures, and assist in analysis for management disclosures and other SEC disclosures
Ensure financial statements are prepared in accordance with US GAAP and SEC regulations, including newly issued accounting pronouncements
Perform technical accounting research on significant or unusual transactions
Assist with ASC 606 revenue recognition matters
Recommend, implement, maintain, and communicate accounting policies and procedures to ensure integrity and consistency
Responsible for stock-based compensation accounting
Assist with the Company’s 404 SOX compliance program, including evaluating controls at service organizations
Work with external SOX partners to ensure timely completion of management testing of controls
Assist with preparation of the annual proxy statement and other ad hoc filings
Prepare supporting schedules for audit committee presentations
Other ad hoc projects as needed

Skills

SEC Reporting

US GAAP

10-K

10-Q

Technical Accounting

SOX 404

ASC 606

Revenue Recognition

Stock-Based Compensation

Financial Statements

CPA

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free